Fucoidan Ameliorates Ferroptosis in Ischemia-reperfusion-induced Liver Injury through Nrf2/HO-1/GPX4 Activation.

Background and Aims: Liver ischemia-reperfusion (IR) injury is a common pathological process in liver surgery. Ferroptosis, which is closely related to lipid peroxidation, has recently been confirmed to be involved in the pathogenesis of IR injury. However, the development of drugs that regulate ferroptosis has been slow, and a complete understanding of the mechanisms underlying ferroptosis has not yet been achieved. Fucoidan (Fu) is a sulfated polysaccharide that has attracted research interest due to its advantages of easy access and wide biological activity. Methods: In this study, we established models of IR injury using erastin as an activator of ferroptosis, with the ferroptosis inhibitor ferrostatin-1 (Fer-1) as the control. We clarified the molecular mechanism of fucoidan in IR-induced ferroptosis by determining lipid peroxidation levels, mitochondrial morphology, and key pathways in theta were involved. Results: Ferroptosis was closely related to IR-induced hepatocyte injury. The use of fucoidan or Fer-1 inhibited ferroptosis by eliminating reactive oxygen species and inhibiting lipid peroxidation and iron accumulation, while those effects were reversed after treatment with erastin. Iron accumulation, mitochondrial membrane rupture, and active oxygen generation related to ferroptosis also inhibited the entry of nuclear factor erythroid 2-related factor 2 (Nrf2) into the nucleus and reduced downstream heme oxygenase-1 (HO-1) and glutathione peroxidase 4 (GPX4) protein levels. However, fucoidan pretreatment produced adaptive changes that reduced irreversible cell damage induced by IR or erastin. Conclusions: Fucoidan inhibited ferroptosis in liver IR injury via the Nrf2/HO-1/GPX4 axis.

Ultrastructure of three Species of Entomoneis (Bacillariophyta) from Lake Qinghai of China, with reference to the external areola occlusions.

Three sympatric Entomoneis species, found at the same specific locality in Lake Qinghai, China, are studied by using light and scanning electron microscope. Two species are proposed as new to science and named as E.sinensis sp. nov. and E.qinghainensis sp. nov. The third species is identified as E.paludosa (W. Smith) Reimer. Entomoneissinensis has a linear-lanceolate valve outline and Ƨ-shaped keel, bears two distinct 8-shaped loops formed by the valvocopula pars media in each cell and each of its stria is composed of either a long hymen strip or a long hymen strip plus one separated areola close to the raphe. Its hymen strip belongs to Type Two, which is a siliceous membrane strip perforated by two rows of linear pores next to transapical costae and two rows of rounded pores between these two rows of linear pores. Entomoneisqinghainensis has large cells, very high keel and evident hymen strip regions like a U-shaped neck pillow at the middle of valve face. Its hymen strip belongs to Type One, which is a siliceous membrane strip perforated by irregularly distributed round pores. Entomoneispaludosa also has the hymen strip regions that are worm-like and close to the raphe canal. Its hymen strip is same as that of E.qinghainensis. The two kinds of the outside areola occlusions in Entomoneis are compared, summarised and discussed.

Two new freshwater species of Surirella (Bacillariophyta) from the Wuling Mountains, China.

Two sympatric Surirella species found at the same specific locality in the Wuling Mountains of China are documented with light and scanning electron microscope. Both species are new to science and named S.wufluminensis sp. nov. and S.suiningensis sp. nov. Surirellawufluminensis has large frustules that are either clockwise or counterclockwise twisted when viewed with the light microscope, and possesses distinctive fibulae, mound-like outgrowths on the valve surface throughout, raised longitudinal ridges on both sides of the raphe, and two helictoglossa-like processes at one apex internally. Surirellasuiningensis has narrowly ovate valve outline, distinctive fibulae, troughs alternating with crests from pole to pole, and two helictoglossa-like processes at one apex internally. These two species do not produce costae on the valve surface in contrast to many species in Surirella. This study provides a further two examples of the wide range of morphological diversity in the genus Surirella.

Revision of the genus Oxyscelio Kieffer (Hymenoptera, Scelionidae) from China.

The genus Oxyscelio Kieffer from China is revised. Thirty-four species are recognized, of which two species are described as new: O. nullicarina Mo Chen, sp. n., O. paracuculli Mo Chen, sp. n., and fourteen species are newly recorded from China: O. aclavae Burks, O. arcus Burks, O. brevidentis Burks, O. excavatus (Kieffer), O. flabelli Burks, O. jaune Burks, O. kiefferi Dodd, O. labis Burks, O. mesiodentis Burks, O. mollitia Burks, O. nasolabii Burks, O. nubbin Burks, O. ogive Burks, and O. reflectens Burks. Keys to the Chinese species are provided.

Increased expression of cellular repressor of E1A-stimulated gene (CREG) in gastric cancer patients: a mechanism of proliferation and metastasis in cancer.

BACKGROUND: The cellular repressor of E1A-stimulated genes (CREG), a secreted glycoprotein, has been studied with human embryonic carcinoma cells, vascular smooth muscle cells, and NIH3T3 fibroblasts. However, its relationship to tumor cell proliferation and metastasis has not been examined in human gastric cancers (GC) until now. AIM: To investigate the expression of CREG in GC and its association with GC cell proliferation and metastasis. METHODS: Forty-two cases of GCs, matched normal gastric tissues, and the human gastric cancer cell lines BGC-823, SGC-7901, MKN45, normal gastric mucosa cell line GES, and HUVEC cell line ECV304 were used to analyze CREG expression at the level of mRNA and protein. The expression of CREG was then further examined by immunohistochemistry in 42 GC tissues, and the correlation between the level of CREG and the pathological and clinical data was evaluated. Finally, we down-regulated the expression of CREG in GC cells with specific siRNA, and assessed the role of CREG in the proliferation and metastasis/invasion of the GC cell line. RESULTS: The level of CREG was found to be higher in malignant GC tissues and cells compared to adjacent normal tissues and normal gastric cells (p < 0.001). Additionally, the expression levels of CREG were positively correlated with tumor clinical stage (p = 0.001), tumor metastasis (p < 0.001), and stages of tumor infiltration (p = 0.019). Furthermore, by using siRNA, we found that the down-regulated expression of CREG inhibited the proliferation of GC cells (p < 0.05), and migration of both GC cells (p = 0.001). CONCLUSIONS: Our data suggest that CREG plays an important role in gastric cancer cell proliferation and metastasis and that CREG may be a potential therapeutic target for GC.

Down-regulation of miR-212 expression by DNA hypermethylation in human gastric cancer cells.

There has been few report discussing the expression and function of miR-212 in gastric cancer (GC). The aim of this pilot study was to investigate the expression of miR-212 in both gastric cancer tissues and gastric cancer cells and further explores the possible reasons for this change and the impact on the development of gastric cancer. qRT-PCR was used to detect the expression of miR-212 in primary GC tissues, adjacent normal tissues, gastric cancer cell lines BGC-823, SGC-7901, MKN-45, and normal gastric mucosa cell line GES. The expression of miR-212 was evaluated before and after treatment with methylation inhibitor-5-Aza-2'-deoxycitidine (5-Aza-dC), finally anti-miRNA and dual luciferase reporter assay were used to prove that MYC is a target gene of miR-212. The results showed that a significant reduction of miR-212 expression in GC tissues was observed compared to that in normal tissues (P = 0.002). At the same time, miR-212 expression level in normal gastric mucosa cell line GES was higher than that of in gastric cancer cell lines BGC-823, SGC-7901, and MKN-45 (P = 0.015, 0.008, 0.044, respectively). Computer sequence analysis showed the hypermethylation of CpG islands(CPI) in the promoter regions of miR-212 led to the lower expression of miR-212 in gastric cell strains (BGC-823 and SGC-7901). MiR-212 expression was significantly recovered after treatment with methylation inhibitor 5-Aza-dC (P = 0.016, 0.000, 0.015, respectively). Then, the results of AMOs transfection and dual luciferase reporter assay showed that Myc is a target of miR-212, which will be helpful to verify the function of miR-212 in carcinogenesis. The conclusion could be deduced from the study that decreased expression of miR-212 may be due to hypermethylation of CPI in gastric cancer cells, and miR-212 might act on the progression of gastric cancer through the potential target gene Myc.